Original Literature | Model OverView |
---|---|
Publication
Title
Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways inmacrophage activation.
Affiliation
Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, NewYork, New York 10021, USA.
Abstract
Macrophage phenotype and activation are regulated by cytokines that use theJak-STAT signaling pathway, microbial recognition receptors that include TLRs,and immunoreceptors that signal via ITAM motifs. The amplitude and qualitativenature of macrophage activation are determined by crosstalk among thesesignaling pathways. Basal ITAM signaling restrains macrophage responses to TLRsand other activating ligands, whereas strong ITAM signals synergize with thesame ligands to activate cells strongly. Similarly, basal ITAM signalingaugments IFN signaling and function of receptor activator of NF-kappaB, butextensive ITAM activation inhibits Jak-STAT signaling. Thus, intensity andduration of ITAM signaling determine whether ITAM-coupled receptors augment orattenuate TLR and Jak-STAT responses. IFN-gamma synergizes with TLRs in part bysuppressing TLR-induced feedback inhibition, mediated by IL-10 and Stat3, by amechanism that depends on glycogen synthase kinase (GSK)3 regulation of AP-1 andCREB. IFN-gamma suppresses TLR2 and TLR4 induction/activation of AP-1 byoverlapping mechanisms that include regulation of MAPKs, GSK3-dependentsuppression of DNA binding, and decreased Fos and Jun protein expression andstability. IFN-gamma suppression of TLR-induced activation of AP-1 anddownstream target genes challenges current concepts about the inflammatory roleof AP-1 proteins in macrophage activation and is consistent with a role for AP-1in the generation of noninflammatory osteoclasts. Jak-STAT, TLR, and ITAMpathways are basally active in macrophages and strongly induced during innateresponses. Thus, signal transduction crosstalk is regulated in a dynamic manner,which differs under homeostatic and pathologic conditions, and dysregulation ofsignal transduction crosstalk may contribute to pathogenesis of chronicinflammatory diseases.
PMID
17502339
|
Entity
Process
c-jun
--
G010232
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93221
10
infinite
0
TRANSFAC | G010232 |
--
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12
10
infinite
0
TRANSPATH | MO000000058 |
--
MAPKs{active}
--
MO000000077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m69
10
infinite
0
TRANSPATH | MO000000077 |
--
PLCgamma{active}
--
MO000000102
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m100
10
infinite
0
TRANSPATH | MO000000102 |
--
PKC{active}
--
MO000000104
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m92
10
infinite
0
TRANSPATH | MO000000104 |
--
Src family
--
MO000000136
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m122
10
infinite
0
TRANSPATH | MO000000136 |
--
AP-1
--
MO000000276
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m219
10
infinite
0
TRANSPATH | MO000000276 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
STAT1
--
MO000013119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1357
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
STAT3
--
MO000013122
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1360
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
STAT1{p}
--
MO000019704
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4238
10
infinite
0
TRANSPATH | MO000019704 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
TLR ligand
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
NF-kappaB{active}
--
e12
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m13
10
infinite
0
TRANSPATH | MO000000058 |
--
IRFs
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
IRFs{active}
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
ERK{active}
--
e15
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17
10
infinite
0
TRANSPATH | MO000000011 |
--
JNK{active}
--
e16
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18
10
infinite
0
TRANSPATH | MO000000023 |
--
p38{active}
--
e17
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19
10
infinite
0
TRANSPATH | MO000000022 |
--
inflammatory genes
--
e19
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m23
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
type I IFN
--
e20
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m24
0
infinite
0
--
type I IFN
--
e21
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
AP-1{p}
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
MMP
--
e23
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
MMP
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
IL-12
--
e25
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m29
0
infinite
0
--
Ets
--
e26
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
Ets{active}
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
CREB/activatingfactor
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
CREB/activatingfactor{act}
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
DNA:histone
--
e30
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m34
0
infinite
0
--
DNA:histone{p}
--
e31
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m35
0
infinite
0
--
IFN-gammaR:JAK
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
IFN-gamma
--
e33
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m37
0
infinite
0
--
IFN-gamma:IFN-gammaR:JAK
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
IFN-gamma:IFN-gammaR:JAK{act}
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
(stat1{p})2
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
(stat1{p})2
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
TLR
--
e40
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m44
0
infinite
0
--
FcgammaRI
--
e41
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m45
0
infinite
0
--
STAT3{active}
--
e42
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m46
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
STAT1{active}
--
e43
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m47
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
IFN-alpha
--
e44
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m48
0
infinite
0
--
DAP12
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
CXCL9
--
e46
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m63
0
infinite
0
--
TREM2 ligand
--
e47
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m64
0
infinite
0
--
TREM2 ligand:TREM2
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
TREM2:DAP12
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
TLR ligand:TLR
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TLR
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
SIRPbeta1:DAP12
--
e63
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m67
0
infinite
0
--
SIRPbeta1:DAP12:ligand
--
e64
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
e65
--
e65
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m70
0
infinite
0
--
NFATc1
--
e66
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
NFATc1
--
e67
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
NFATc1{active}
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
Semaphorin 6D
--
e69
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m74
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
plexin A1-TREM2-DAP12
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
plexin A1-TREM2-DAP12-Semaphorin 6D
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
LPS:TLR4
--
e72
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m77
0
infinite
0
--
TLR2 ligand:TLR2
--
e74
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m79
0
infinite
0
--
TLR2 ligand
--
e75
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m80
0
infinite
0
--
GSK-3beta
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m83
0
infinite
0
--
gsk-3beta{p}
--
e78
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m84
0
infinite
0
--
csml-variable:Double
m85
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
csml-variable:Double
m86
0
infinite
0
--
MMP1
--
e81
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m87
0
infinite
0
--
ITAM receptor lgand: ITAM receptor
--
e82
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m88
0
infinite
0
--
ITAM receptor
--
e83
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m89
0
infinite
0
--
ITAM receptor ligand
--
e84
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m90
0
infinite
0
--
csml-variable:Double
m91
0
infinite
0
--
ITAM receptor lgand: ITAM receptor:ITAM
--
e86
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m93
0
infinite
0
--
ITAM receptor lgand: ITAM receptor:ITAM{p}
--
e87
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m94
0
infinite
0
--
ITAM receptor lgand: ITAM receptor:ITAM{p}:syk
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m95
0
infinite
0
--
PTK
--
e89
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m96
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
PTK{active}
--
e90
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m97
0
infinite
0
--
ca2+
--
e92
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m99
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6*m11*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m24*0.1
nodelay
--
0
PMID: 17502339 IRFs are induced or activated by TLR ligation and are particularly important in driving Type I IFN production and downstream activation of IFN-inducible genes.
p11
p11
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c30 : 1
stoichiometry:c29 : 1
m219*m17*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
p12
p12
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c33 : 1
stoichiometry:c32 : 1
m219*m18*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
p13
p13
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c35 : 1
m219*m19*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c37 : 1
m17*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c39 : 1
m18*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c41 : 1
m19*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c45 : 1
m19*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c44 : 1
m18*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c43 : 1
m17*0.1
nodelay
--
0
PMID: 17502339 MAPKs induce the expression of AP-1 family transcription factors such as Fos and Jun and activate the transcriptional activity of AP-1 proteins by phosphorylation of their transcription activation domains.
p2
p2
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c14 : 1
stoichiometry:c5 : 1
m12*m5*0.1
nodelay
--
0
PMID: 17502339 TLR signaling results in the downstream activation of three major families of proteins important in activating inflammatory gene expression: NF-{kappa}B/Rel proteins; IRFs; and MAPKs¡½the ERKs and the stress kinases JNK and p38.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c87 : 1
stoichiometry:c86 : 1
m34*m17*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c49 : 1
m26*0.1
nodelay
--
0
PMID: 17502339 AP-1 proteins have been implicated in invasive cell growth and matrix metalloprotease (MMP) production and in cell line models, have been suggested to mediate induction of inflammatory genes such as TNF-{alpha}.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m26*0.1
nodelay
--
0
PMID: 17502339 AP-1 proteins have been implicated in invasive cell growth and matrix metalloprotease (MMP) production and in cell line models, have been suggested to mediate induction of inflammatory genes such as TNF-{alpha}.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c55 : 1
stoichiometry:c54 : 1
m27*m26*0.1
nodelay
--
0
PMID: 17502339 AP-1 proteins have been implicated in invasive cell growth and matrix metalloprotease (MMP) production and in cell line models, have been suggested to mediate induction of inflammatory genes such as TNF-{alpha}.
p24
p24
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
1.0*0.1
nodelay
--
0
PMID: 17502339, 15067049, 15123779 Fos actually suppresses the expression of IL-12.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c64 : 1
stoichiometry:c59 : 1
m30*m17*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c65 : 1
stoichiometry:c61 : 1
m30*m18*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c66 : 1
stoichiometry:c63 : 1
m30*m19*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c73 : 1
stoichiometry:c68 : 1
m32*m17*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c74 : 1
stoichiometry:c70 : 1
m32*m18*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c15 : 1
stoichiometry:c7 : 1
m14*m5*0.1
nodelay
--
0
PMID: 17502339 TLR signaling results in the downstream activation of three major families of proteins important in activating inflammatory gene expression: NF-{kappa}B/Rel proteins; IRFs; and MAPKs¡½the ERKs and the stress kinases JNK and p38.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c75 : 1
stoichiometry:c72 : 1
m32*m19*0.1
nodelay
--
0
--
p31
p31
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c82 : 1
stoichiometry:c79 : 1
m93309*m17*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
p32
p32
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c84 : 1
stoichiometry:c81 : 1
m93309*m19*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
p33
p33
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c83 : 1
stoichiometry:c80 : 1
m93309*m18*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c90 : 1
stoichiometry:c89 : 1
m34*m18*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c93 : 1
stoichiometry:c92 : 1
m34*m19*0.1
nodelay
--
0
PMID: 17502339, 11743587 MAPKs can activate Ets and CREB/activating transcription factor, stabilize mRNAs, which encode inflammatory cytokines, induce efficient translation of TNF-{alpha} mRNA, and lead to phosphorylation of histones at inflammatory gene loci
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m37*m36*0.1
nodelay
--
0
PMID: 17502339 Binding of IFN-{gamma} to its cell surface receptor leads to the activation of receptor-associated Jak protein tyrosine kinases, followed by tyrosine phosphorylation and activation of latent cytoplasmic proteins¡½STATs¡½which in turn, dimerize and translocate to the nucleus, where they bind to promoter sequences and activate transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m38*0.1
nodelay
--
0
PMID: 17502339 Binding of IFN- to its cell surface receptor leads to the activation of receptor-associated Jak protein tyrosine kinases, followed by tyrosine phosphorylation and activation of latent cytoplasmic proteins¡½STATs¡½which in turn, dimerize and translocate to the nucleus, where they bind to promoter sequences and activate transcription.
p38
p38
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c101 : 1
stoichiometry:c100 : 1
m1357*m39*0.1
nodelay
--
0
PMID: 17502339 Binding of IFN-gamma to its cell surface receptor leads to the activation of receptor-associated Jak protein tyrosine kinases, followed by tyrosine phosphorylation and activation of latent cytoplasmic proteins¡½STATs¡½which in turn, dimerize and translocate to the nucleus, where they bind to promoter sequences and activate transcription. PMID: 17502339 IFN-{gamma} activates Stat1 predominantly, which mediates the activating functions of IFN-{gamma}, including enhanced microbial killing, increased antigen presentation, and enhanced inflammatory cytokine production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m4238*0.1
nodelay
--
0
PMID: 17502339 Binding of IFN-gamma to its cell surface receptor leads to the activation of receptor-associated Jak protein tyrosine kinases, followed by tyrosine phosphorylation and activation of latent cytoplasmic proteins¡½STATs¡½which in turn, dimerize and translocate to the nucleus, where they bind to promoter sequences and activate transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c17 : 1
stoichiometry:c9 : 1
m16*m5*0.1
nodelay
--
0
PMID: 17502339 TLR signaling results in the downstream activation of three major families of proteins important in activating inflammatory gene expression: NF-{kappa}B/Rel proteins; IRFs; and MAPKs¡½the ERKs and the stress kinases JNK and p38.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m40*0.1
nodelay
--
0
PMID: 17502339 Binding of IFN- to its cell surface receptor leads to the activation of receptor-associated Jak protein tyrosine kinases, followed by tyrosine phosphorylation and activation of latent cytoplasmic proteins¡½STATs¡½which in turn, dimerize and translocate to the nucleus, where they bind to promoter sequences and activate transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m42*m41*0.1
nodelay
--
0
PMID: 17502339 Binding of IFN- to its cell surface receptor leads to the activation of receptor-associated Jak protein tyrosine kinases, followed by tyrosine phosphorylation and activation of latent cytoplasmic proteins¡½STATs¡½which in turn, dimerize and translocate to the nucleus, where they bind to promoter sequences and activate transcription.
p42
p42
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c111 : 1
stoichiometry:c110 : 1
m1357*m69*0.1
nodelay
--
0
PMID: 17502339 STAT transcriptional activity is potentiated by serine phosphorylation of transcription activation domains, which can be mediated by multiple kinases, including MAPKs, PKC, and calmodulin-dependent protein kinase II. PMID: 17502339 IFN-{gamma} activates Stat1 predominantly, which mediates the activating functions of IFN-{gamma}, including enhanced microbial killing, increased antigen presentation, and enhanced inflammatory cytokine production.
p43
p43
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c114 : 1
stoichiometry:c113 : 1
m1357*m92*0.1
nodelay
--
0
PMID: 17502339 STAT transcriptional activity is potentiated by serine phosphorylation of transcription activation domains, which can be mediated by multiple kinases, including MAPKs, PKC, and calmodulin-dependent protein kinase II. PMID: 17502339 IFN-{gamma} activates Stat1 predominantly, which mediates the activating functions of IFN-{gamma}, including enhanced microbial killing, increased antigen presentation, and enhanced inflammatory cytokine production.
p44
p44
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c117 : 1
stoichiometry:c116 : 1
m1357*m1023*0.1
nodelay
--
0
PMID: 17502339 STAT transcriptional activity is potentiated by serine phosphorylation of transcription activation domains, which can be mediated by multiple kinases, including MAPKs, PKC, and calmodulin-dependent protein kinase II. PMID: 17502339 IFN-{gamma} activates Stat1 predominantly, which mediates the activating functions of IFN-{gamma}, including enhanced microbial killing, increased antigen presentation, and enhanced inflammatory cytokine production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c118 : 1
m39*0.1
nodelay
--
0
PMID: 17502339 IFN-{gamma}-induced increases in TLR and Fc{gamma}RI expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c119 : 1
m39*0.1
nodelay
--
0
PMID: 17502339 IFN-{gamma}-induced increases in TLR and Fc{gamma}RI expression
p47
p47
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c124 : 1
stoichiometry:c123 : 1
m12*m39*0.1
nodelay
--
0
PMID: 17502339 IFN-gamma enhanced activation of NF-{kappa}B
p48
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c193 : 1
stoichiometry:c127 : 1
m2103*m1360*0.1
nodelay
--
0
PMID: 17502339 Stat1, which is activated by IFN-{gamma}, and Stat3, activated by IL-10, oppose each other¡Çs activity in the regulation of inflammation PMID: 17502339, 16713974 We reported recently that IFN-{gamma} suppresses TLR-mediated induction of IL-10 expression and downstream Stat3 activation, thereby interrupting a TLR2-induced feedback inhibition loop
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c130 : 1
stoichiometry:c129 : 1
m1360*m25*0.1
nodelay
--
0
PMID: 17502339, 16571725 Pleiotropic cytokines such as Type I IFNs and IL-6 activate Stat1 and Stat3, and the balance between Stat1 and Stat3 activation by these cytokines can determine the balance of their pro- and anti-inflammatory functions.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c16 : 1
stoichiometry:c11 : 1
m21*m5*0.1
nodelay
--
0
PMID: 17502339 TLR signaling results in the downstream activation of three major families of proteins important in activating inflammatory gene expression: NF-{kappa}B/Rel proteins; IRFs; and MAPKs¡½the ERKs and the stress kinases JNK and p38.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c133 : 1
stoichiometry:c132 : 1
m1360*m871*0.1
nodelay
--
0
--
p51
p51
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c136 : 1
stoichiometry:c135 : 1
m1357*m871*0.1
nodelay
--
0
PMID: 17502339, 16571725 Pleiotropic cytokines such as Type I IFNs and IL-6 activate Stat1 and Stat3, and the balance between Stat1 and Stat3 activation by these cytokines can determine the balance of their pro- and anti-inflammatory functions.
p52
p52
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c139 : 1
stoichiometry:c138 : 1
m1357*m25*0.1
nodelay
--
0
PMID: 17502339, 16571725 Pleiotropic cytokines such as Type I IFNs and IL-6 activate Stat1 and Stat3, and the balance between Stat1 and Stat3 activation by these cytokines can determine the balance of their pro- and anti-inflammatory functions.
p53
p53
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c142 : 1
stoichiometry:c143 : 1
stoichiometry:c144 : 1
stoichiometry:c141 : 1
m1357*m48*m49*m2891*0.1
nodelay
--
0
PMID: 17502339 IFN-{alpha}-induced activation of Stat1 is amplified by the ITAM-containing adapters FcR{gamma} and DAP12 and the downstream kinase Syk, which can phosphorylate Stat1 directly or could phosphorylate IFNAR Stat1-docking sites.
p54
p54
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c147 : 1
stoichiometry:c146 : 1
m1357*m1066*0.1
nodelay
--
0
PMID: 17502339 IFN-{alpha}-induced activation of Stat1 is amplified by the ITAM-containing adapters FcR{gamma} and DAP12 and the downstream kinase Syk, which can phosphorylate Stat1 directly or could phosphorylate IFNAR Stat1-docking sites.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c148 : 1
m41*0.1
nodelay
--
0
PMID: 17502339 The shift in IFN-{alpha}-induced STAT activation toward increased Stat1 activation relative to Stat2 and Stat3 activation results in enhanced expression of Stat1-dependent inflammatory genes such as the chemokines CXCL9 and CXCL10 and a shift to a more inflammatory phenotype.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c150 : 1
m41*0.1
nodelay
--
0
PMID: 17502339 The shift in IFN-{alpha}-induced STAT activation toward increased Stat1 activation relative to Stat2 and Stat3 activation results in enhanced expression of Stat1-dependent inflammatory genes such as the chemokines CXCL9 and CXCL10 and a shift to a more inflammatory phenotype.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c152 : 1
stoichiometry:c154 : 1
m64*m66*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c157 : 1
stoichiometry:c156 : 1
m67*m70*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c159 : 1
m65*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c18 : 1
stoichiometry:c13 : 1
m20*m5*0.1
nodelay
--
0
PMID: 17502339 TLR signaling results in the downstream activation of three major families of proteins important in activating inflammatory gene expression: NF-{kappa}B/Rel proteins; IRFs; and MAPKs¡½the ERKs and the stress kinases JNK and p38.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c158 : 1
m68*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c166 : 1
stoichiometry:c164 : 1
m71*m65*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c167 : 1
stoichiometry:c165 : 1
m71*m68*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c172 : 1
stoichiometry:c169 : 1
m72*m65*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c173 : 1
stoichiometry:c171 : 1
m72*m68*0.1
nodelay
--
0
PMID: 17502339 Ligation of the DAP12-associated, ITAM-coupled receptors TREM2 and SIRP¦Â1 by endogenous ligands, expressed on myeloid lineage osteoclast precursors, "costimulates" RANK signaling by regulating calcium oscillations, leading to expression and activation of NFATc1 and osteoclastogenesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
m75*m74*0.1
nodelay
--
0
PMID: 17502339, 16715077 A recent, exciting discovery identified Semaphorin 6D as an endogenous ligand for a receptor complex containing plexin A1-TREM2-DAP12
p66
p66
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c177 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 17502339 Consistent with intact MAPK activation, LPS-induced Fos and Jun mRNA expression was not inhibited in IFN-{gamma}-preactivated macrophages.
p67
p67
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c180 : 1
stoichiometry:c182 : 1
stoichiometry:c181 : 1
m78*m77*0.1
nodelay
--
0
PMID: 17502339 Consistent with intact MAPK activation, LPS-induced Fos and Jun mRNA expression was not inhibited in IFN-{gamma}-preactivated macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c183 : 1
m77*0.1
nodelay
--
0
PMID: 17502339 Consistent with intact MAPK activation, LPS-induced Fos and Jun mRNA expression was not inhibited in IFN-{gamma}-preactivated macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c185 : 1
m77*0.1
nodelay
--
0
PMID: 17502339 Consistent with intact MAPK activation, LPS-induced Fos and Jun mRNA expression was not inhibited in IFN-{gamma}-preactivated macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c21 : 1
stoichiometry:c20 : 1
m13*m5*0.1
nodelay
--
0
PMID: 17502339 NF-{kappa}B proteins are transcription factors whose nuclear translocation is triggered by TLR ligands, and NF-{kappa}B plays a key role in the transcriptional activation of multiple inflammatory genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c189 : 1
stoichiometry:c188 : 1
m3964*m80*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c192 : 1
stoichiometry:c190 : 1
m79*0.1
nodelay
--
0
PMID: 17502339, 16713974 We reported recently that IFN-{gamma} suppresses TLR-mediated induction of IL-10 expression and downstream Stat3 activation, thereby interrupting a TLR2-induced feedback inhibition loop
p72
p72
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c196 : 1
stoichiometry:c197 : 1
stoichiometry:c195 : 1
m78*m79*0.1
nodelay
--
0
PMID: 17502339 The mechanism of inhibition of TLR2-induced IL-10 production involves attenuation of TLR2-induced MAPK activation, which results in diminished AP-1 (Fos and Jun) expression and diminished CREB phosphorylation on the transcription-activating site serine 13
p73
p73
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c198 : 1
stoichiometry:c200 : 1
stoichiometry:c201 : 1
stoichiometry:c199 : 1
m2057*m69*0.1
nodelay
--
0
PMID: 17502339 The mechanism of inhibition of TLR2-induced IL-10 production involves attenuation of TLR2-induced MAPK activation, which results in diminished AP-1 (Fos and Jun) expression and diminished CREB phosphorylation on the transcription-activating site serine 13
p74
p74
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c204 : 1
stoichiometry:c205 : 1
stoichiometry:c203 : 1
m81*m79*0.1
nodelay
--
0
PMID: 17502339 In addition, IFN-{gamma} suppresses TLR2-induced Akt activity, which is linked with decreased phosphorylation and increased activity of GSK3¦Â, which in turn, contributes to inhibition of AP-1 DNA binding, likely by phosphorylation of the Jun DNA-binding domain
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c207 : 1
m83*m82*0.1
nodelay
--
0
PMID: 17502339 In addition, IFN-{gamma} suppresses TLR2-induced Akt activity, which is linked with decreased phosphorylation and increased activity of GSK3¦Â, which in turn, contributes to inhibition of AP-1 DNA binding, likely by phosphorylation of the Jun DNA-binding domain
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c213 : 1
stoichiometry:c211 : 1
m85*m26*0.1
nodelay
--
0
PMID: 17502339 IFN-{gamma} suppresses TLR2-induced Akt activity, linked with decreased phosphorylation and increased activity of GSK3¦Â, which in turn, contributes to inhibition of AP-1 DNA binding.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c216 : 1
stoichiometry:c214 : 1
m79*0.1
nodelay
--
0
PMID: 17502339, 16713974 Diminished AP-1 and CREB activity in IFN-{gamma}-primed, TLR2-activated cells leads to decreased expression of AP-1 and CREB target genes, including MMP-1 (collagenase), plasminogen activator inhibitor-2 (PAI-2), and IL-10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c219 : 1
stoichiometry:c217 : 1
m79*0.1
nodelay
--
0
PMID: 17502339, 16713974 Diminished AP-1 and CREB activity in IFN-{gamma}-primed, TLR2-activated cells leads to decreased expression of AP-1 and CREB target genes, including MMP-1 (collagenase), plasminogen activator inhibitor-2 (PAI-2), and IL-10
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c221 : 1
stoichiometry:c222 : 1
m90*m89*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m22*0.1
nodelay
--
0
PMID: 17502339 NF-{kappa}B proteins are transcription factors whose nuclear translocation is triggered by TLR ligands, and NF-{kappa}B plays a key role in the transcriptional activation of multiple inflammatory genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c224 : 1
stoichiometry:c225 : 1
m88*m91*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p81
p81
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c228 : 1
stoichiometry:c227 : 1
m93*m122*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p82
p82
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c229 : 1
stoichiometry:c230 : 1
stoichiometry:c231 : 1
m94*m1066*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c232 : 1
stoichiometry:c234 : 1
stoichiometry:c233 : 1
m96*m95*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p84
p84
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c235 : 1
stoichiometry:c237 : 1
stoichiometry:c236 : 1
m12*m95*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p85
p85
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c240 : 1
stoichiometry:c239 : 1
m78*m95*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p86
p86
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c243 : 1
stoichiometry:c242 : 1
m98*m95*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p87
p87
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c244 : 1
stoichiometry:c246 : 1
stoichiometry:c245 : 1
m101*m95*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
p88
p88
cso30:i:ME_UnknownProduction
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c248 : 1
m100*0.1
nodelay
--
0
PMID: 17502339 ITAM-mediated signaling is initiated by Src family kinase phosphorylation of the two ITAM motif tyrosines, leading to the recruitment and activation of the PTK Syk and downstream signaling pathways, which include activation of PTKs, NF-{kappa}B, MAPKs, and protein kinase C (PKC) and calcium-mediated signaling pathways (via activation of phospholipase C{gamma}).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c24 : 1
m15*0.1
nodelay
--
0
PMID: 17502339 IRFs are induced or activated by TLR ligation and are particularly important in driving Type I IFN production and downstream activation of IFN-inducible genes.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--